Abstract
Are small molecules or biologics the drugs of the future? Small-molecule drugs have historically been the pillars of traditional medicine. However, recently, we seem to be amidst a scientific revolution with the rise of many FDA-approved biologic drugs. This opinion article looks at the current state of small molecules and biologics and assesses what the future holds for these two broad classes of drugs.
| Original language | English |
|---|---|
| Pages (from-to) | 757-758 |
| Number of pages | 2 |
| Journal | MedChemComm |
| Volume | 9 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2018 |
Bibliographical note
Publisher Copyright:© 2018 The Royal Society of Chemistry.
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Drug Discovery
- Organic Chemistry